Table 2 Clinical characteristics and metabolic parameters of female subjects with type-2 diabetes, pre-diabetes and healthy control subjects
From: Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic Saudis
| Â | No diabetes | Pre-diabetes | Type-2 diabetes |
|---|---|---|---|
N | 35 | 37 | 45 |
Age (years) | 43.6(11.3) | 43.3(11.7) | 49.0(12.6)d |
Systolic blood pressure (mm Hg) | 122.8(23.1) | 127.3(24.2) | 123.6(18.6) |
Diastolic blood pressure (mm Hg) | 79.4(16.5) | 79.8(8.03) | 80.7(10.3) |
BMI (kg/m2) | 30.4(6.4) | 32.5(8.4) | 32.5(10.3) |
Waist (cm) | 90.5(12.5) | 91.8(13.5) | 96.2(17.9) |
Hips (cm) | 105.3(14.1) | 104.8(17.9) | 106.7(20.8) |
Fasting Glucose (mmol/L) | 4.8(0.9) | 6.1(0.4)b | 14.1(5.5)b |
Cholesterol (mmol/L) | 5.2(1.3) | 5.3(1.1) | 6.6(1.9)b |
HDL (mmol/L) | 1.1(0.4) | 0.9(0.4) | 1.1(0.3) |
Triglyceride (mmol/L) | 1.9(1.9) | 1.6(0.9) | 2.6(1.4) |
LDL (mmol/L) | 3.5(1.4) | 3.6(1.1)d | 4.4(1.5)c |
Insulin (μmol/L)* | 15.2(2–62) | 13.5(6–26) | 14.04(1–52) |
Leptin ng/mL * | 10.2(0.25–34.8) | 14.09(2.8–44.4)a | 13.3(3.6–49.1) |
APO A1 mg/dL | 0.8(0.4) | 0.9(0.4) | 1.2(2.5) |
APO A11 mg/dL | 0.4(0.1) | 0.4(0.1) | 0.4(0.2) |
HOMA IR * | 3.1(0.3–12.5) | 3.6(1.5–7.3) | 7.8(0.6–28.4)b |